michigan glp-1 pancreatitis lawsuit AFFF Pancreatic Cancer [July 2026 Update] GLP-1 Lawsuit | Stomach Paralysis,

The most effective therapy available now is Zepbound, which causes about 20% weight loss

Recent research shows mixed findings on the mental health risks of GLP-1 receptor agonists

Therefore, the rise in the increasing obesity rates is driving the growth of the weight loss drugs industry

An Ozempic class action lawsuit was filed in July 2023 in both Louisiana and California federal courts against the makers of Ozempic, with multiple plaintiffs alleging they were not sufficiently warned about the potential side effects of the drug, including damage to their gallbladder

Solid line indicates reduction in amyloid burden associated with higher endogenous GLP-1 concentration (pg/ml)

Semaglutide has a longer track record and more published long-term safety data, which some patients and providers find reassuring